Cary Street Partners Investment Advisory’s Medpace MEDP Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Sell	207 -10	-5%	-$4.62K	0.02%	485
2026 Q1	$104K	Sell	217 -7	-3%	-$3.58K	0.03%	445
2025 Q4	$126K	Buy	224 +1	+0.4%	+$568	0.03%	395
2025 Q3	$115K	Buy	223 +8	+4%	+$3.49K	0.05%	345
2025 Q2	$67.5K	Buy	215 +180	+514%	+$54K	0.03%	367
2025 Q1	$10.7K	Buy	35 +19	+119%	+$6.39K	0.01%	481
2024 Q4	$5.32K	Sell	16 -1,057	-99%	-$358K	﹤0.01%	463
2024 Q3	$358K	Buy	1,073 +6	+0.6%	+$2.28K	0.01%	578
2024 Q2	$439K	Buy	1,067 +7	+0.7%	+$2.77K	0.02%	504
2024 Q1	$428K	Sell	1,060 -55	-5%	-$19.3K	0.02%	487
2023 Q4	$342K	Hold	1,115	–	–	0.02%	506
2023 Q3	$270K	Hold	1,115	–	–	0.01%	498
2023 Q2	$268K	Hold	1,115	–	–	0.02%	451
2023 Q1	$210K	Sell	1,115 -5	-0.4%	-$1.03K	0.02%	459
2022 Q4	$238K	Buy	+1,120	New	+$224K	0.02%	438
2022 Q3	–	Sell	-1,260	Closed	-$189K	–	536
2022 Q2	$189K	Buy	+1,260	New	+$182K	0.02%	426

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cary Street Partners Investment Advisory's MEDP Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Medpace (MEDP) stake by 4.6% in Q2 2026, selling an estimated $4.62K and leaving 207 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #485.

Cary Street Partners Investment Advisory first reported a position in MEDP in Q2 2022 and has held it in 16 quarters since. The position peaked at $439K in Q2 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Cary Street Partners Investment Advisory held 207 shares of Medpace worth $110K as of Q2 2026.
Cary Street Partners Investment Advisory sold 10 Medpace shares in Q2 2026, an estimated $4.62K.
Medpace made up 0.02% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #485 holding.
Cary Street Partners Investment Advisory first reported a position in Medpace in Q2 2022 and has held it in 16 quarters since.
Cary Street Partners Investment Advisory's Medpace position peaked at $439K in Q2 2024.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.